Cargando…

The ubiquitous ‘cancer mutational signature’ 5 occurs specifically in cancers with deleted FHIT alleles

The FHIT gene is located at the fragile FRA3B locus where activation by carcinogen-induced and endogenous replication stress causes FHIT deletions even in normal cells over a lifetime. Our lab has shown that loss of FHIT expression causes genome instability and provides single-strand DNA substrates...

Descripción completa

Detalles Bibliográficos
Autores principales: Volinia, Stefano, Druck, Teresa, Paisie, Carolyn A., Schrock, Morgan S., Huebner, Kay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731946/
https://www.ncbi.nlm.nih.gov/pubmed/29254236
http://dx.doi.org/10.18632/oncotarget.22321
_version_ 1783286596977557504
author Volinia, Stefano
Druck, Teresa
Paisie, Carolyn A.
Schrock, Morgan S.
Huebner, Kay
author_facet Volinia, Stefano
Druck, Teresa
Paisie, Carolyn A.
Schrock, Morgan S.
Huebner, Kay
author_sort Volinia, Stefano
collection PubMed
description The FHIT gene is located at the fragile FRA3B locus where activation by carcinogen-induced and endogenous replication stress causes FHIT deletions even in normal cells over a lifetime. Our lab has shown that loss of FHIT expression causes genome instability and provides single-strand DNA substrates for APOBEC3B hypermutation, in line with evidence that FHIT locus deletions occur in many cancers. Based on these biological features, we hypothesized that FHIT loss drives development of COSMIC mutational signature 5 and here provide evidence, including data mining of >6,500 TCGA samples, that FHIT is the cancer-associated gene with copy number alterations correlating most significantly with signature 5 mutation rate. In addition, tissues of Fhit-deficient mice exhibit a mutational signature strongly resembling signature 5 (cosine similarity value = 0.89). We conclude that FHIT loss is a molecular determinant for signature 5 mutations, which occur in all cancer types early in cancer development, are clock-like, and accelerated by carcinogen exposure. Loss of FHIT caretaker function may be a predictive and preventive marker for cancer development.
format Online
Article
Text
id pubmed-5731946
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-57319462017-12-17 The ubiquitous ‘cancer mutational signature’ 5 occurs specifically in cancers with deleted FHIT alleles Volinia, Stefano Druck, Teresa Paisie, Carolyn A. Schrock, Morgan S. Huebner, Kay Oncotarget Research Paper The FHIT gene is located at the fragile FRA3B locus where activation by carcinogen-induced and endogenous replication stress causes FHIT deletions even in normal cells over a lifetime. Our lab has shown that loss of FHIT expression causes genome instability and provides single-strand DNA substrates for APOBEC3B hypermutation, in line with evidence that FHIT locus deletions occur in many cancers. Based on these biological features, we hypothesized that FHIT loss drives development of COSMIC mutational signature 5 and here provide evidence, including data mining of >6,500 TCGA samples, that FHIT is the cancer-associated gene with copy number alterations correlating most significantly with signature 5 mutation rate. In addition, tissues of Fhit-deficient mice exhibit a mutational signature strongly resembling signature 5 (cosine similarity value = 0.89). We conclude that FHIT loss is a molecular determinant for signature 5 mutations, which occur in all cancer types early in cancer development, are clock-like, and accelerated by carcinogen exposure. Loss of FHIT caretaker function may be a predictive and preventive marker for cancer development. Impact Journals LLC 2017-11-06 /pmc/articles/PMC5731946/ /pubmed/29254236 http://dx.doi.org/10.18632/oncotarget.22321 Text en Copyright: © 2017 Volinia et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (http://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Volinia, Stefano
Druck, Teresa
Paisie, Carolyn A.
Schrock, Morgan S.
Huebner, Kay
The ubiquitous ‘cancer mutational signature’ 5 occurs specifically in cancers with deleted FHIT alleles
title The ubiquitous ‘cancer mutational signature’ 5 occurs specifically in cancers with deleted FHIT alleles
title_full The ubiquitous ‘cancer mutational signature’ 5 occurs specifically in cancers with deleted FHIT alleles
title_fullStr The ubiquitous ‘cancer mutational signature’ 5 occurs specifically in cancers with deleted FHIT alleles
title_full_unstemmed The ubiquitous ‘cancer mutational signature’ 5 occurs specifically in cancers with deleted FHIT alleles
title_short The ubiquitous ‘cancer mutational signature’ 5 occurs specifically in cancers with deleted FHIT alleles
title_sort ubiquitous ‘cancer mutational signature’ 5 occurs specifically in cancers with deleted fhit alleles
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731946/
https://www.ncbi.nlm.nih.gov/pubmed/29254236
http://dx.doi.org/10.18632/oncotarget.22321
work_keys_str_mv AT voliniastefano theubiquitouscancermutationalsignature5occursspecificallyincancerswithdeletedfhitalleles
AT druckteresa theubiquitouscancermutationalsignature5occursspecificallyincancerswithdeletedfhitalleles
AT paisiecarolyna theubiquitouscancermutationalsignature5occursspecificallyincancerswithdeletedfhitalleles
AT schrockmorgans theubiquitouscancermutationalsignature5occursspecificallyincancerswithdeletedfhitalleles
AT huebnerkay theubiquitouscancermutationalsignature5occursspecificallyincancerswithdeletedfhitalleles
AT voliniastefano ubiquitouscancermutationalsignature5occursspecificallyincancerswithdeletedfhitalleles
AT druckteresa ubiquitouscancermutationalsignature5occursspecificallyincancerswithdeletedfhitalleles
AT paisiecarolyna ubiquitouscancermutationalsignature5occursspecificallyincancerswithdeletedfhitalleles
AT schrockmorgans ubiquitouscancermutationalsignature5occursspecificallyincancerswithdeletedfhitalleles
AT huebnerkay ubiquitouscancermutationalsignature5occursspecificallyincancerswithdeletedfhitalleles